checkAd

     109  0 Kommentare INTERIM REPORT FOR Q3 2022/23 - Seite 3

    The presentation can be downloaded from Ambu.com/presentations.

     

    Ambu A/S
    Baltorpbakken 13
    DK-2750 Ballerup, Denmark
    Tel.: +45 7225 2000
    CVR no.: 63 64 49 19
    Ambu.com

     

    CONTACT

    Investors
    Thomas Frederik Schmidt
    Chief Financial Officer
    tfsc@ambu.com
    +45 2084 0500

    Anders Hjort
    Head of Investor Relations
    anhj@ambu.com
    +45 2892 8881

    Nicolai Thomsen
    Director, Strategic Finance
    nith@ambu.com
    +45 2620 8047


    Media

    Tine Bjørn Schmidt
    Head of Corporate Communications
    tisc@ambu.com
    +45 2264 0697

     

    ABOUT AMBU
    Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia and patient monitoring solutions. Headquartered near Copenhagen in Denmark, Ambu employs around 4,500 people in Europe, North America, Latin America and Asia Pacific. For more information, please visit Ambu.com.

    Attachment


    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    INTERIM REPORT FOR Q3 2022/23 - Seite 3 In Q3 2022/23, Ambu delivered 8% organic revenue growth and a 7.6% EBIT margin. This was driven by Endoscopy Solutions growing 23%, due to high double-digit growth within urology and ENT, and pulmonology returning to positive growth year-over-year. …